GENERICS AND MANUFACTURING

Cortellis Generics Intelligence & Biopharma Global Pricing Trends

Understand the global generics landscape and make better decisions

Speak to our team

Make life-saving treatments more accessible

Make timely and data-driven business decisions in the highly competitive and fast-changing biopharma generics and biosimilars markets with a comprehensive, single source of market performance, patent and manufacturing data.

Have confidence you’re making the most informed IP, sourcing, portfolio and business development decisions using reliable and integrated data in a single, easily searchable solution. Strategically develop your portfolio, find API suppliers, gain insight on when drugs lose exclusivity and monitor your competition.

How we help

  1. Pinpoint when a drug will go generic to expand your portfolio
    Identify when a drug will lose exclusivity and identify new launch opportunities using expertly curated and searchable data compiled into a Constraint Date Forecast and Product Selector Tool.
  2. Efficiently plan launches
    Make data-driven decisions to inform your launch strategies, sales forecasts and commercial plans with easily accessible and digestible global sales, kg consumption, pack price and market share data all in a single, trusted solution.
  3. Understand global biopharma pricing trends
    Inform product selection or portfolio rationalization with a better understanding of market dynamics, dose form advantage and reimbursement trends provided by comparable currency and historical biopharma pricing data.

Why choose us

All-inclusive data in a single, integrated location

  • 72K+ companies, including API and dose manufacturers.
  • 61 K+ small molecules and biologics
  • 26 K+ supplementary protection certificates.
  • 1.1M+ worldwide patents, including patent families, SPCs and patent litigation.
  • 18 K+ synthesis schemes.

Pharma global pricing trends

  • Optional module to optimize biopharma pricing strategies, anticipate payer pressure, determine impact on market access and plan future launches.
  • Generic biopharma pricing and reimbursement intelligence of final dose formulations across 90+ markets.
  • Historical market share and generic pharma pricing data of up to 5 years for United States and Latin America markets.

Easy-to-use, intuitive tools

Constraint Date Forecast:

  • Identifies earliest time a drug can enter the generic market.
  • Based on several data sources such as constraining patents, exclusivities and SPCs.
  • Includes one date for each country.

Product and company selectors:

  • Provide ability to quickly identify new launch opportunities based on specific criteria.
  • Connect ~50 product and company criteria around LOE, market potential and competitiveness.

Timely updates and alerts

  • Daily updates for US patent challenges.
  • Weekly updates for manufacturing and patent intelligence.
  • Monthly or quarterly updates for market performance.
  • Customizable email alerts for new or updated product or company data.

Related products

BIOPHARMA INTELLIGENCE | DISCOVERY, CLINICAL & REGULATORY

Cortellis CMC Intelligence
Developing a drug is difficult. Going to market shouldn’t be.

Life Sciences and Healthcare Consulting Services
Improving patient lives by helping clients discover, develop and bring new treatments and devices to market.
CONSULTING & SERVICES 

Connect with an Expert
We provide strategic guidance, professional services, custom data and transformative intelligence across the healthcare ecosystem. Our teams fuel innovation in R&D, Commercial Strategy, Evidence, Value and Assessment and Technology enablement.

Resources

REPORT  

The future of the generics landscape
ON-DEMAND WEBINAR

Biosimilars in Oncology
INFOGRAPHIC 

Finding alternate supplies of API sources

Want to learn more?

Contact us to schedule a demo of Cortellis Biopharma Generics Intelligence.

Speak to our team